Skip to main content
S 701 111th Congress Senate Health Cancer Drug therapy Government studies and investigations Health information and medical records Health technology, devices, supplies Home and outpatient care Immunology and vaccination Medicare Public contracts and procurement

Medicare Patient IVIG Access Act of 2009

Introduced: March 25, 2009 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 25, 2009
Read twice and referred to the Committee on Finance.
Mar 25, 2009
Sponsor introductory remarks on measure. (CR S3792-3793)
Mar 25, 2009
Introduced in Senate
 Plain-English summary Congressional Research Service

Medicare Patient IVIG Access Act of 2009 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to direct the Secretary of Health and Human Services to collect data on the differences, if any, between: (1) payments to physicians for immune globulins using average sales price payment methodology; and (2) costs incurred by physicians for furnishing these products. Requires the Secretary also to review data on the access of eligible individuals to immune globulins.

Requires the Secretary, after completion of the review, to provide, if appropriate, an additional payment to such physicians for all items related to the furnishing of immune globulins as part of hospital outpatient services.

Provides for Medicare coverage of and payment for intravenous immune globulin (IVIG) administered in the home.

Allows the Secretary to contract for the collection of data on the practice of IVIG infusion.

Directs the Secretary to review data collected under such a contract as well as data submitted by members of the medical community related to the current infusion payment codes under part B (Supplementary Medical Insurance) of SSA title XVIII.

Requires the Secretary, upon completion of any data collection and review, to: (1) notify the appropriate Medicare administrative contractors regarding which existing infusion codes shall be used for purposes of part B IVIG reimbursement; or (2) report to Congress and the RBRUS Committee (RUC) on why an additional infusion payment code is necessary.

Extends the meaning of durable medical equipment to include disposable drug delivery systems, including elastomeric infusion pumps, for the treatment of colorectal cancer.

What's happening now March 25, 2009

Read twice and referred to the Committee on Finance.

 Committees of jurisdiction 1
 Cosponsors 4
All 4 Democratic 4